Peptides and polypeptides as modulators of the immune response: thymopentin — an example with unknown mode of action
Authors:
- S GonserSGS Gonser
- E WeberEWE Weber
- G FolkersGFG Folkers
- 30 June 1999
- journal article
- review article
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 73 (6) , 265-273
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Clinical applications of TNF-α in cancerCurrent Opinion in Immunology, 1998
- Characterization of the Chromatin Binding Activity of Lamina-Associated Polypeptide (LAP) 2Biochemical and Biophysical Research Communications, 1997
- Current and future clinical applications of interferon-gamma in host antimicrobial defenseIntensive Care Medicine, 1996
- Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of myeloid leukemiaCurrent Opinion in Hematology, 1995
- Tumour necrosis factor and cancerProgress in Growth Factor Research, 1992
- Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiencyJournal of Clinical Immunology, 1989
- Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.Journal of Experimental Medicine, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agentsInternational Journal of Immunopharmacology, 1981